Table 28:
# Studies (Design) | Risk of Bias | Inconsistency | Indirectness | Imprecision | Publication Bias | Upgrade Considerations | Quality |
---|---|---|---|---|---|---|---|
2 RCTs | No serious limitations | No serious limitations | Serious limitations (−1)a | Serious limitations (−1)b | Undetected | None | ⊕⊕ Low |
4 non-RCTs | Serious limitations (−1)c | Serious limitations (−1)d | Serious limitations (−1)a | Serious limitations (−1)b | Undetected | None | ⊕ Very low |
Abbreviations: GRADE, Grading of Recommendations Assessment, Development, and Evaluation; RCT, randomized controlled trial.
Surrogate outcome for patient-important outcome of cancer-free survival or cancer-specific mortality. Impact of potential differences in method of pathological assessment of positive surgical margin.
Not powered to detect differences.
Nonrandomized studies start at low GRADE. Differences in baseline patient, tumour, or surgeon characteristics between groups may affect outcome.
Inconsistency in significance of results.